Day: September 10, 2021

Posted on

‫جي دبليو أم تكشف عن سياراتها الجديدة في معرض آي أيه أيه موبيليتي للاستحواذ على سوق الطاقة الجديدة بميزة المحرك الأول

باودنغ، الصين، 10 أيلول/يوليو، 2021 / PRNewswire/ — يوم 6 أيلول/سبتمبر، افتتح معرض آي أيه أيه موبيليتي أبوابه رسميا في ميونيخ.  شركة جي دبليو أم كشفت عن سيارتها الرباعية الدفع الفارهة “وي” (WEY) وماركة سيارة الطاقة الجديدة أورا (ORA).

GWM Unveils Its New Cars at IAA Mobility 2021 to Seize the New Energy Market in Europe with First-mover Advantage

استجابة لشعار “الطريق المتنقل إلى حيادية الكربون” في معرض السيارات هذا، عرضت جي دبليو أم موديلات سياراتها التي تعمل بالطاقة الجديدة مثل WEY Coffee 01 PHEV و ORA 01CAT.  الموديل الإستراتيجي العالمي لسيارة وي، Coffee 01 PHEV  يعيد تعريف السيارات الذكية الأوروبية بمداه الطويل الفريد، وقيادته الذكية وقمرة قيادته الذكية؛ كما يعتبر الموديلORA 01CAT  مزيجا مثاليا من الجماليات الكلاسيكية القديمة والتكنولوجيا المستقبلية، وهو الذي سيوفر تجربة منتج غير مسبوقة للمستخدمين الأوروبيين.  سيساعد الموديلان معًا جي دبليو أم على استكشاف سوق سيارات الطاقة الجديدة في أوروبا.  في الواقع، أصبحت السيارات الكهربائية والسيارات حيادية الكربون والاستدامة هي الاتجاهات الرئيسية لتطوير سوق السيارات العالمي في المستقبل، وقد أدركت جي دبليو أم بالفعل الفرص واتخذت الترتيبات مسبقًا.  منذ وقت ليس بالبعيد، تم إنتاج أول بطارية خالية من الكوبالت طورتها شركة سفولت، وهي شركة تابعة لـ جي دبليو أم، بكميات كبيرة وتحميلها في المركبات، مما أدى إلى كسر اعتماد بطاريات سيارات الطاقة الجديدة على الكوبالت وحل المشكلة العالمية المتمثلة في أن موارد الكوبالت غير قابلة للتجديد.  تم تجهيز السيارة الرياضية متعددة الاستخدامات A + الكهربائية بالكامل تحت العلامة التجارية أورا لأول مرة ببطارية خالية من الكوبالت وتحقق إنتاجها الضخم.  يبلغ مدى هذا الموديل من سيارات الدفع الرباعي أكثر من 600 كيلومتر في ظل ظروف التشغيل العادية، مع الحفاظ على ميزة الأداء القوي، ويمكنه تحقيق 100 كيلومتر من التسارع خلال 5 ثوانٍ.  علاوة على ذلك، يصل أداء مقاومة الماء في هذا الموديل إلى IP67 ولديه قدرة عالية على الاحتفاظ بالطاقة والتسخين السريع في درجات الحرارة المنخفضة.

تلتزم جي دبليو أم دائما بمفهوم “الاستثمار الضخم” في البحث والتطوير في مجال الطاقة الجديدة.  استثمرت جي دبليو أم أكثر من 500 مليون يوان صيني في البحث والتطوير لبطاريات الليثيوم الخالية من الكوبالت.  أجرى أكثر من 1200 من موظفي البحث والتطوير و 120 من خبراء المواد والبطاريات أكثر من 200 اختبار تجريبي وأكثر من 3000 عملية تحقق من الأداء الكهربائي وأخيراً أزالوا عنصر الكوبالت في مادة الأنود، مما حقق تطبيق بطاريات خالية من الكوبالت تماما.  في السنوات الخمس المقبلة، ستستثمر جي دبليو أم 100 مليار يوان في البحث والتطوير في مجالات الطاقة الجديدة والذكاء لإنشاء منتجات أكثر أمانًا وبيئة وذكاء للمستخدمين في جميع أنحاء العالم.

يعتقد خبراء الصناعة أن بطارية جي دبليو أم الخالية من الكوبالت قد كسرت الاحتكار التكنولوجي للدول الأوروبية والولايات المتحدة واليابان وكوريا الجنوبية من خلال ابتكارات الشركة الأصلية الأساسية، وخلقت حقبة خالية من الكوبالت في مجال الطاقة الجديدة.  في المستقبل، وفقًا للاتجاه العالمي للطاقة الجديدة، ستواصل جي دبليو أم زيادة الاستثمار في مجال البحث والتطوير التكنولوجي في مجال الطاقة الجديدة، ومواصلة الابتكار والاستمرار، وتصدر الصناعة في مسار الطاقة الجديد بقوة وثقة كافيين.

صورة – https://mma.prnewswire.com/media/1611889/GWM.jpg

Posted on

Miami International Holdings Reports August 2021 Trading Results, MIAX Exchange Group Sets New Market Share and Volume Records; SPIKES Futures Volume at Record Levels

PRINCETON, N.J., Sept. 10, 2021 /PRNewswire/ — Miami International Holdings, Inc. today reported August 2021 trading results for its U.S. exchange subsidiaries – MIAX®, MIAX Pearl® and MIAX Emerald® (together, the MIAX Exchange Group™) and the Minneapolis Grain Exchange (MGEX).

MIAX_Logo

The MIAX Exchange Group reported a number of new volume and market share records for multi-list options trading including a 16.82% single day market share record on August 6, 2021.  In addition, MIAX Emerald reported a 5.49% market share record for August 2021 and a monthly volume record of 41,821,523 contracts.  The total U.S. multi-listed options market share of 15.23% in August 2021 was 304 basis points higher than the 12.19% market share in August 2020 and represented a 24.9% increase.

The MIAX Exchange Group collectively executed over 116.0 million multi-listed options contracts in August 2021, representing an average daily volume (ADV) of 5,273,340 contracts.

In U.S. equities, MIAX Pearl Equities™ executed 772,501,802 shares in August 2021, a monthly volume record and an increase of 4.2% from July 2021. The August 2021 total also represented a market share record of .39%.

In U.S. futures, MGEX executed 394,528 contracts in August 2021, the 3rd highest monthly total volume on record and representing an increase of 23.7% from the August 2020 total.  Total volume during the January to August 2021 period reached 2,475,882 contracts, a 33.0% increase from the same period in 2020, while open interest totaled 82,128 contracts on August 31, 2021, an increase of 33.2% from the August 31, 2020 total.

SPIKES® Futures volume totaled a record 85,885 contracts in August 2021, up 156.3% from the 33,510 contract total in July 2021.  SPIKES Futures volume reached a record ADV of 3,904 contracts in August 2021.  In addition, SPIKES Futures volume on September 9, 2021 totaled a new daily record volume of 14,890 contracts.

Multi-Listed Options Trading Volume for

 MIAX Exchange Group, Current Month

 Year-to-Date Comparison
Multi-Listed Options
Contracts		 Aug-21 Aug-20 % Chg Jul-21 % Chg Aug-21 Aug-20 % Chg
Trading Days 22 21 21 167 168
U.S. Equity Options Industry 761,891,872 582,394,732 30.8% 749,029,013 1.7% 6,132,683,722 4,413,767,683 38.9%
MIAX Exchange Group 116,013,478 70,996,814 63.4% 116,326,908 -0.3% 878,372,405 518,728,761 69.3%
MIAX Options 47,123,249 28,298,707 66.5% 49,303,729 -4.4% 340,247,261 205,900,750 65.2%
MIAX Pearl 27,068,706 23,805,458 13.7% 34,237,820 -20.9% 301,731,215 204,748,354 47.4%
MIAX Emerald 41,821,523 18,892,649 121.4% 32,785,359 27.6% 236,393,929 108,079,657 118.7%
Multi-Listed Options ADV Aug-21 Aug-20 % Chg Jul-21 % Chg Aug-21 Aug-20 % Chg
U.S. Multi-Listed Options Industry 34,631,449 27,733,082 24.9% 35,668,048 -2.9% 36,722,657 26,272,427 39.8%
MIAX Exchange Group 5,273,340 3,380,801 56.0% 5,539,377 -4.8% 5,259,715 3,087,671 70.3%
MIAX 2,141,966 1,347,557 59.0% 2,347,797 -8.8% 2,037,409 1,225,600 66.2%
MIAX Pearl 1,230,396 1,133,593 8.5% 1,630,372 -24.5% 1,806,774 1,218,740 48.2%
MIAX Emerald 1,900,978 899,650 111.3% 1,561,208 21.8% 1,415,533 643,331 120.0%
Multi-Listed Options Market Share for

MIAX Exchange Group, Current Month

 Year-to-Date Comparison
Multi-Listed Options Market
Share		 Aug-21 Aug-20 % Chg Jul-21 % Chg Aug-21 Aug-20 % Chg
MIAX Exchange Group 15.23% 12.19% 24.9% 15.53% -2.0% 14.32% 11.75% 21.9%
MIAX 6.19% 4.86% 27.3% 6.58% -6.0% 5.55% 4.66% 18.9%
MIAX Pearl 3.55% 4.09% -13.1% 4.57% -22.3% 4.92% 4.64% 6.1%
MIAX Emerald 5.49% 3.24% 69.2% 4.38% 25.4% 3.85% 2.45% 57.4%
Equities Trading Volume for

MIAX Pearl Equities, Current Month

 Year-to-Date Comparison
Equities Shares (millions) Aug-21 Aug-20 % Chg Jul-21 % Chg Aug-21 Aug-20 % Chg
Trading Days 22 21 21 167 168
U.S. Equities Volume – Industry 198,022 0 NA 204,551 -3.2% 1,958,438 0 NA
MIAX Pearl Volume 773 0 NA 741 4.2% 4,708 0 NA
MIAX Pearl ADV 35 0 NA 35 -0.5% 28 0 NA
MIAX Pearl Market Share 0.39% NA NA 0.36% 7.7% 0.24% NA NA
Futures & Options Trading Volume for

MGEX, Current Month

 Year-to-Date Comparison
Futures & Options

Contracts

 Aug-21 Aug-20 % Chg Jul-21 % Chg Aug-21 Aug-20 % Chg
Trading Days 22 21 21 167 168
MGEX Volume 394,528 318,992 23.7% 297,235 32.7% 2,475,882 1,861,398 33.0%
MGEX ADV 17,933 15,190 18.1% 14,154 26.7% 14,826 11,080 33.8%

July 2021 Market Share and Volume Records:

MIAX Exchange Group Multi-Listed Options Records
Single Day Market Share 16.82% August 6, 2021
MIAX Emerald Multi-Listed Options Records
Monthly Market Share 5.49% August 2021
Monthly Volume 41,821,523 August 2021

For further information regarding MIAX, please visit www.MIAXOptions.com or contact MIAX Trading Operations at TradingOperations@MIAXOptions.com.

Corporate Communications Contacts:

Andy Nybo, SVP, Chief Communications Officer
(609) 955-2091
anybo@miami-holdings.com

About MIAX
MIAX’s parent holding company, Miami International Holdings, Inc., owns Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), the Minneapolis Grain Exchange, LLC (MGEX), and the Bermuda Stock Exchange (BSX).

MIAX, MIAX Pearl and MIAX Emerald are national securities exchanges registered with the Securities and Exchange Commission (SEC) that leverage MIAX’s industry-leading technology and infrastructure to provide U.S. listed options trading to their member firms. MIAX serves as the exclusive exchange venue for cash-settled options on the SPIKES® Volatility Index (Ticker: SPIKE), a measure of the expected 30-day volatility in the SPDR® S&P 500® ETF (SPY). In addition to options, MIAX Pearl facilitates the trading of cash equities through MIAX Pearl Equities™.

MGEX is a registered exchange with the Commodity Futures Trading Commission (CFTC) and is a Notice Registered Securities Futures Product Exchange with the SEC. MGEX serves as the exclusive market for a variety of products, including Hard Red Spring Wheat and SPIKES Futures. In addition, MGEX is a Designated Contract Market (DCM) and Derivatives Clearing Organization (DCO) under the CFTC, providing DCM, DCO and cash market services in an array of asset classes.

The BSX is a leading electronic international securities market regulated by the Bermuda Monetary Authority (BMA) specializing in the listing and trading of capital market instruments such as equities, debt issues, funds, hedge funds, derivative warrants and insurance linked securities. A full member of the World Federation of Exchanges and affiliate member of the International Organization of Securities Commissions, the BSX is globally recognized, including by the SEC.

MIAX’s executive offices and National Operations Center are located in Princeton, NJ, with additional offices located in Miami, FL, Minneapolis, MN, and Hamilton, Bermuda.

To learn more about MIAX visit www.MIAXOptions.com.

To learn more about MGEX visit www.mgex.com.

To learn more about the BSX visit www.BSX.com.

Disclaimer and Cautionary Note Regarding Forward-Looking Statements
The press release shall not constitute an offer to sell or a solicitation of an offer to purchase any securities of Miami International Holdings, Inc. (together with its subsidiaries, the Company), and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer; solicitation or sale would be unlawful. This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

All third-party trademarks (including logos and icons) referenced by the Company remain the property of their respective owners. Unless specifically identified as such, the Company’s use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between the owners of these trademarks and the Company. Any references by the Company to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Logo – https://mma.prnewswire.com/media/1396492/MIAX_Logo.jpg

Posted on

Wiseasy Partners with UnionPay International to Boost Digital Banking and QR Payment in Ghana and Nigeria

ACCRA, Ghana, Sept. 10, 2021 /PRNewswire/ — Wiseasy Group, a leading global digital banking and payment builder, jointly announced a collaborative partnership with UnionPay International (UPI) today, to accelerate digital banking and QR payment in Ghana and Nigeria in supporting the global digital transformation trend.

In response to the rapid changing of customer payment needs and the increasingly competitive global financial arena, the two entities collaboratively implement a comprehensive solution, bridging the gaps with their advanced core competencies. This solution provides a unified mobile payment standard and facilitates the management of financial institutions’ mobile payment businesses. Rapid diffusion by Smartphones and QR open new prospects for the development of innovative payment methods and enable customers to carry out banking operations while on the move.

“Wiseasy Group is pleased to be part of this exciting collaboration with UPI to launch a secured, seamless and innovative solution that meets the new expectations of retailers and customers,” stated Mr. Rachid Oulad Akdim, VP Group and President of Wiseasy France.

“We are honoured to partner with Wiseasy Group to further accelerate the brand reach in Ghana and Nigeria”, said Mr. Luping Zhang, General Manager of UnionPay International Africa Branch. “UnionPay continues to offer high quality, cost-effective, innovative payment services through shared growth with our partners in the region”.

Wiseasy Group is a leading global digital banking and payment builder, operating in 114 countries and regions worldwide, covering dozens of industries. The company aims to promote the innovation, development, and application of digital banking solutions and payment technology worldwide by offering smart fintech terminals and rich payment technology services that can reach wider demographics with more convenience.

With over 1.6 billion UnionPay cards issued in 70 countries and regions globally, UnionPay has expanded its acceptance network to 180 countries and regions in recent years. At present, UnionPay cards are widely accepted in Africa across all sectors, effectively meeting the diverse purchasing needs of UnionPay cardholders visiting and living on the continent. UnionPay cards are issued in over 10 African countries, including Kenya, Tanzania, Uganda, Ghana, South Africa, Madagascar and Mauritius. The Nilson Report (Issue 1154) shows that UnionPay ranks first among all card schemes in card issuance and transaction volume worldwide. UnionPay has launched various innovative payment products in Africa in response to the worldwide digital transformation and financial inclusion.

Posted on

‫شبكة تلفزيون الصين الدولية (‏CGTN): تعزيز التعاون بين الصين والمملكة المتحدة بشأن تغير المناخ والتنوع البيولوجي

بكين، 10 سبتمبر 2021 /PRNewswire/ — أعربت الصين والمملكة المتحدة عن استعدادهما لتعزيز الحوار والتعاون في معالجة تغير المناخ العالمي وتحقيق نتائج إيجابية في مؤتمر الأمم المتحدة المقبل بشأن تغير المناخ والقمة العالمية للتنوع البيولوجي.

China and the UK have maintained a good cooperative relationship in coping with climate change./CFP

قدم نائب رئيس مجلس الدولة الصيني هان تشنغ، وألوك شارما الرئيس المعين لمؤتمر الأمم المتحدة لتغير المناخ 2021 (COP26)، التأكيد خلال اجتماع بالفيديو يوم الثلاثاء.

أن مؤتمر الأمم المتحدة لتغير المناخ 2021 (COP26) سيعقد في جلاسكو، في اسكتلندا، في شهر نوفمبر، بينما سيعقد الاجتماع الخامس عشر لمؤتمر الأطراف في اتفاقية الأمم المتحدة للتنوع البيولوجي (COP15) في مدينة كونمينغ جنوب الصين عبر الإنترنت في أكتوبر 2021 وعلى أرض الواقع في أكتوبر 2022.

وأكد هان أن التضامن والتعاون العالميين ضروريان لمواجهة تغير المناخ.

وأعرب هان عن توقعاته بشأن مؤتمر الأمم المتحدة لتغير المناخ 2021 (COP26)، وأمله في أن يرسل مؤتمر المناخ إشارة سياسية قوية لدعم التعددية بحزم، ولضمان احترام القواعد المتعددة الأطراف وتعزيز الإجراءات. وأشار أيضًا إلى توقعاته بأن يقوم مندوبو مؤتمر الأمم المتحدة لتغير المناخ 2021 (COP26) بتحويل الأهداف المناخية إلى سياسات وإجراءات محددة، آملًا في استكمال المفاوضات للوفاء باتفاقية باريس.

وأشار هان إلى أن البلدين حافظا على تعاون جيد في التعامل مع تغير المناخ، ووضعا أهدافًا أقوى لخفض انبعاثات الكربون للوفاء بحياد الكربون، ودعا الجانبين أيضًا إلى استغلال مزاياهما وتعزيز الحوار المتعلق بتغير المناخ.

وقال هان إن الصين، التي تتولى رئاسة الدورة الخامسة عشرة لمؤتمر الأطراف، مستعدة للعمل مع المملكة المتحدة لتعزيز نجاح المؤتمرين.

وأشاد شارما بجهود الصين في معالجة تغير المناخ، وقال إن المملكة المتحدة تتطلع إلى توسيع التبادل والتعاون في مجالات مثل مجال تمويل المناخ والطاقة وتجارة الكربون، وأنها على استعداد لتعزيز الحوار والتنسيق مع الصين لتحقيق نتائج إيجابية في مؤتمري COP26 وCOP15.

صورة – https://mma.prnewswire.com/media/1612098/Image1.jpg

 للتواصل الإعلامي: جيانغ سيمين، 3286-2655-188-86+، cgtn@cgtn.com

Posted on

Malawi Businessman Convicted for 2019 Attempt to Bribe Judges

BLANTYRE, MALAWI – Malawi’s high court has found a businessman guilty of attempting to bribe Constitutional Court judges who were ruling on the disputed 2019 presidential election.

Thomson Mpinganjira, who owns a commercial bank in Malawi, was arrested in January 2020 by the Anti-Corruption Bureau, or ACB, after the High Court’s chief justice, Andrew Nyirenda, reported he had attempted to bribe the judges.

Mpinganjira was accused of offering judges an unspecified amount of money so that a court case over the disputed 2019 presidential election would end in favor of then-president Peter Mutharika.

Mpinganjira had pleaded not guilty to six bribery-related charges. But High Court Judge Dorothy DeGabriele, in her judgment Friday, said the court proved beyond a reasonable doubt that Mpinganjira wanted to bribe the five judges.

“The court found the accused person under count 1 and 2 for offering an advantage to Justice [Healey] Potani and Justice [Michael] Tembo who were public officers and for the benefit of that advantage to be shared amongst the judges, to induce the judges to make a decision in favor of the respondent. The accused person is hereby convicted accordingly,” DeGabriele said.

Mpinganjira’s lawyer, Tamando Chokotho, asked the court to consider giving his client noncustodial punishment, saying his client is a first offender and a responsible man.

Reyneck Matemba, Malawi’s solicitor general, dismissed calls for the noncustodial sentence, saying the convict needs a maximum prison term to serve as a lesson to potential offenders.

“What the convict wanted to do, the offense which he has committed, is a very serious offense,” Matemba said. “He wanted to defeat the course of justice in one of the most high-profile cases in this country, ever.”

Following the conviction, DeGabriele revoked Mpinganjira’s bail and remanded him to Chichiri Prison in Blantyre, where he will await his sentencing.

 

Source: Voice of America

Posted on

African Union Suspends Guinea After Coup

The African Union said on Friday it was suspending Guinea after a coup in the West African country that saw its president Alpha Conde arrested.

The pan-African body said on Twitter that it “decides to suspend the Republic of Guinea from all AU activities and decision-making bodies”.

The move came after Guinean special forces seized power on Sunday and arrested Conde, who had come under increasing fire for perceived authoritarianism.

The AU had on Sunday condemned the military takeover and called for the release of Conde, who became the country’s first democratically elected president in 2010.

Its move came a day after the Economic Community of West African States (ECOWAS) also suspended Guinea and said it was sending a mission to the country to evaluate the situation there.

The AU’s Political Affairs, Peace and Security Council said it called on AU Commission chief Moussa Faki to “engage with stakeholders in the region” on the crisis.

 

Source: Voice of America

Posted on

Violence Against Civilians in Eastern DRC Reaching New Heights, UN Says

GENEVA – The U.N. refugee agency is calling for more effective measures to protect millions of civilians in eastern Democratic Republic of Congo subjected to killings, kidnappings and savage abuse by armed groups.

Dozens of armed groups have been committing violence against civilians in eastern DRC for more than two decades, but the U.N. refugee agency says the viciousness and magnitude of the attacks have reached a level not seen before.

The UNHCR and its partners have recorded more than 1,200 civilian deaths and 1,100 rapes in 2021 in the two most affected provinces of North Kivu and Ituri. The agency says ferocious attacks have driven more than one million Congolese in the eastern part of the country from their homes this year alone.

UNHCR spokesman Boris Cheshirkov says most assaults have been perpetrated by the Allied Democratic Forces, a rebel group with Ugandan roots operating in eastern DRC. He says the group’s attacks have been increasing in brutality and frequency since late 2020.

“These reports are coming in again and again. Twenty-five-thousand human rights violations for this year, including extortion, including looting, certainly sexual violence. Horrific reports that our staff and our partners are receiving and the extreme violence against civilians. So, our call is very clear. This is a call that we are constantly making. We need more measures to protect civilians,” Cheshirkov said.

Violence and abuse have displaced more than five million people inside the DRC, the second highest number of internally displaced after Syria. Cheshirkov says repeated displacement is putting enormous financial pressure on impoverished host communities, and risking wearing out those communities’ welcome mat.

“Harsh living conditions and a lack of food often trigger premature return by displaced people to their place of origin, further exposing them to abuse and violence,” Cheshirkov said. “In fact, returnees account for 65 percent of the serious human rights abuses that we and our partners have recorded.”

Cheshirkov notes that the lifesaving needs of this ever-growing displaced population are increasing. But his agency, he says, can only respond to a fraction of them because it is out of money.

With less than four months left in 2021, he says the UNHCR has received only 51 percent of the $205 million required to carry out humanitarian operations in the DRC this year.

 

Source: Voice of America

Posted on

‫تتصدر بورش، وميلت لايف، وسي في إس هيلث، وديفيد هورساجر العناوين الرئيسية لقمة SAFe® في 27/سبتمبر- ا/10

تركز أجندة 2021 على مرونة الأعمال المؤسسية، وتسريع التحول الرقمي في عصر ملئ بالاضطرابات الثورية

بولدر، كولورادو، 10 / سبتمبر/2021/PRNewswire/ —  أعلنت  Scaled Agile, Inc مزود SAFe®، والرائدة عالميا في مرونة الأعمال عن التشكيلة الكاملة من المتحدثين، والنقاط الأساسية المتعلقة ب أOnline 2021 Global SAFe Summit  . يمثل الحدث الذي تستمر فعالياته ليومين أكبر تقارب عالمي للمتخصصين في SAFe ورواد الفكر الصناعي المهتمين بتسريع التحول الرقمي، والتنافس في السوق سريع التطور.

The two-day 2021 Global SAFe Summit will be online in three time zones, Americas, Europe, and Asia.

وقد سجل ما يزيد عن 1500 شخص من الشركات العالمية الرائدة في هذا الحدث الذي يُعقد فيما بين 27/سبتمبر- وحتى 1/أكتوبر في ثلاث مناطق زمنية: الولايات المتحدة الأمريكية، وأوروبا، وآسيا وسوف يقدم ما يزيد عن 50 متحدث النقاط الرئيسية، والمحادثات التقنية، وقصص العملاء من بورش، وسي في إس هيلث، ودويتشة تيليكوم، وكايزر بيرمينانت، وتي في جلوب، و زد كي إتش، ونورث روب جرومان، والقوات الجوية في الولايات المتحدة الأمريكية.

تتضمن النقاط الرئيسية:

— The Trust Edge™: كيف يقود كبار القادة والمنظمات نتائج الأعمال اعتمادً على الثقة- – يشارك المؤلف الأكثر مبيعا، ديفيد هورساجر أعماله بشأن الثقة، وسبب اعتبارها عاملا أساسيا لفرق عمل أجايل، والأعمال، وكيفية استخدامها كتعزيز قوي لأي من شركات SAFe.

— تصميم المستقبل الرقمي في بورش  يتشارك كلا من المديران التنفيذيان في بورش ماتياس أولبريش، و الدكتور أوليفر سبفيرت كيفية تجمعت الاتجاهات المنفصلة لهندسة المركبات ووتكنولوجيا المعلومات لإعادة تصور السيارات الرياضية في المستقبل.

— CVS Health #OneStepCloser – كيف تعاملت سي في إس هيلث مع الاضطراب الضخم من خلال استجابتها الضخمة والمتطورة لكوفيد 19

 — رحلة SAFe – The MetLife Agile المذهلة – تتيح  SAFe Fellow Cgeryl Crupi منهجا دقيقا لتطبيق SAFe في مساحات كبيرة من المؤسسة

— الإبحار في المستقبل من خلال تدفق قيمة مرونة الأعمال – يكشف مؤسس SAFe، دين ليفنجويل منهجا فريدا للشركة يساعد الشركات في رحلة تحولها.

التسجيل متاح الآن علىglobal.safesummit.com.

حول Scaled Agile, Inc

تعتبر Scaled Agile, Inc مقدم  SAFe® ، رائدة عالميا في مجال مرونة الأعمال. من خلال التعليم، والشهادة، وشبكة الشريك العالمية، والمجتمع المتطور لأكثر من 800000 من المتخصصين المدربين، تساعد Scaled Agile الشركات في تحقيق المرونة في ثقافتهم، ومن ثم سرعة تحديد وتقديم قيمة العملاء، والاستفادة من الفرص الناشئة، وتحسين نتائج الأعمال. تعرف على المزيد من خلال scaledagile.com.

فيديو- https://mma.prnewswire.com/media/1611820/summitpromo.mp4
Photo – https://mma.prnewswire.com/media/1611723/2021_Global_Summit_Social_Reg_Open_Dates.jpg

Posted on

Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19

Independent Data Monitoring Committee Supports Expansion to Adolescents and Pregnant and Nursing Women Based on Safety and Tolerability Data from Phase 2 Lead-In

WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced that the independent data monitoring committee (IDMC) for the EVADE Phase 2/3 trial of ADG20 for the prevention of COVID-19 has provided a recommendation to expand Phase 3 trial enrollment to include adolescents and pregnant or nursing women, as well as to decrease the protocol-specified, post injection monitoring time. The IDMC’s assessments are based on their review of unblinded safety and tolerability data from 200 participants enrolled in the Phase 2 lead-in portion of the trial. Adagio remains blinded to the data and plans to implement the IDMC recommendations for the Phase 3 portion of the trial. EVADE is being conducted globally, including in regions where there is a high prevalence of SARS-CoV-2 variants of concern, to evaluate the ability of a single, intramuscular dose of ADG20 to prevent COVID-19 in both pre- and post-exposure settings.

“Given the urgent need for additional treatment and preventative options for COVID-19, particularly in vulnerable populations, we are pleased that an independent assessment of the safety data from the lead-in portion of EVADE supported inclusion of adolescents and pregnant or nursing women in the next phase of the study,” said Lynn Connolly, M.D., Ph.D., chief medical officer of Adagio. “Based on the potent and broad activity of ADG20 in non-clinical studies, as well as its extended half-life and ease of administration, we believe this antibody has the potential to become a preferred prophylactic option for COVID-19, particularly for vulnerable groups such as children and the immunocompromised, for whom there are currently limited or no available options.”

The EVADE trial is a global, multi-center, double-blind, placebo-controlled clinical trial evaluating ADG20 in two independent cohorts. The first cohort (post-exposure prophylaxis) is designed to assess the safety and efficacy of ADG20 compared to placebo for the prevention of COVID-19 after exposure to an individual with laboratory confirmed SARS-CoV-2 infection. The second cohort (pre-exposure prophylaxis) is designed to assess the efficacy and safety of ADG20 compared to placebo in individuals who are at increased risk for SARS-CoV-2 infection due to occupational, housing or recreational situations, and in individuals who are at increased risk of poor vaccine response, including individuals with compromised immune systems or other co-morbidities. The primary efficacy endpoint in both cohorts is the prevention of laboratory confirmed, symptomatic COVID-19. For more information on the EVADE trial, please visit https://clinicaltrials.gov/ct2/show/NCT04859517.

The clinical development program for ADG20 includes two additional trials: the ongoing Phase 1 clinical trial of ADG20 in healthy volunteers and the ongoing STAMP trial evaluating ADG20 as a treatment for high-risk individuals with mild or moderate COVID-19 (see clinicaltrials.gov).

About ADG20
ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses, is being developed for the prevention and treatment of COVID-19, the disease caused by SARS-CoV-2. ADG20 was designed and engineered to possess high potency and broad neutralization against SARS-CoV-2 and additional clade 1 sarbecoviruses, by targeting a highly conserved epitope in the receptor binding domain. ADG20 displays potent neutralizing activity against the original SARS-CoV-2 strain as well as all known variants of concern. ADG20 has the potential to impact viral replication and subsequent disease through multiple mechanisms of action, including direct blocking of viral entry into the host cell (neutralization) and elimination of infected host cells through Fc-mediated innate immune effector activity. ADG20 is formulated at high concentrations, enabling intramuscular administration, and was engineered to have a long half-life, with a goal of providing both rapid and durable protection. Adagio is advancing ADG20 through multiple clinical trials on a global basis.

About Adagio Therapeutics
Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with third-party contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch. For more information, please visit www.adagiotx.com.

Contacts:
Media Contact:
Dan Budwick, 1AB
Dan@1abmedia.com

Investor Contact:
Monique Allaire, THRUST Strategic Communications
monique@thrustsc.com


Posted on

‫دراسة مرض السكري أبيليتي ديابتيس العالمية ترحب بالمريض الألف في الدراسة: تحقيق معلم كبير

تامبا، فلوريدا10 سبتمبر / أيلول 2021/PRNewswire/ —  بدأت دراسة مرض السكري أبيليتي ديابتيس العالمية (وهي تجربة مقارنة عشوائية بين Abluminus DES+ Sirolimus-Elut مقابل الدعامات المزيلة للإيفيروليموس لدى مرضى الشريان التاجي  المصابين  بمرض السكري العالمي) بمؤشر تسجيل المرضى يوم 11  </72 حزيران/يونيو 2020 في إيطاليا (في ذروة الموجة الأولى </78  من جائحة كوفيد-19)على يد الأستاذ أنطونيو كولومبو، وظلت وتيرة التسجل في الدراسة منذ ذلك الحين ثابتة ومتسقة، حيث تم تسجيل ألف مريض في هذه الدراسة في أكثر من عام بقليل.

Concept Medical Lights Up NY Times Square to celebrate the enrollment of 1000 patients for ABILITY

على الرغم من أن جائحة كوفيد-19 لا تزال تعصف بالعالم، إلا أن وتيرة التسجيل في الدراسة رائعة بالنظر إلى حقيقة أن مرافق الرعاية الصحية مشغولة برعاية المرضى المصابين بكوفيد-19 في المستشفى.  على الرغم من أن أزمة كوفيد-19 لا تزال تلوح في الأفق، إلا أن أمراض القلب والأوعية الدموية تظل السبب الأول للوفيات في العالم، ولا يزال مرض السكري هو المرض المشترك الرئيسي والمساهم في التسبب في أمراض الشريان التاجي.

دراسة مرض السكري أبيليتي ديابتيس العالمية  هي أكبر تجربة عشوائية مضبوطة في العالم لمرضى الشريان التاجي المصابين بداء السكري كمرض مشترك. تقيس هذه التجربة العشوائية المضبوطة سلامة وفعالية Abluminus DES + المصمم خصيصًا بتقنية Envisolution الحاصلة على براءة الاختراع التي أثبتت فعاليتها في إدارة أمراض الشريان التاجي التكاثرية التي تظهر لدى مرضى السكري.

ومع وتيرة التسجيل الواعدة حتى الآن، تتطلع شركة كونسيبت ميديكالتتطلع شركة كونسيبت ميديكال بشغف إلى إكمال ونتائج دراسة مرض السكري أبيليتي ديابتيس العالمية التي تستهدف أكثر من 3000 مريض بالسكري، عبر 100 مركز، تشمل أكثر من 25 دولة ضد عائلة XIENCE EES (الأوعية الدموية أبوت).

Concept Medical Logo

يسر شركة كونسيبت ميديكال أن تكون جزءًا من هذا الإنجاز الذي هو نتيجة مباشرة للدعم اللامتناهي والتوجيه والخبرة من البروفيسورة روكسانا مهران (الرئيسة)، البروفيسورة ماري كلود موريس (المديرة الطبية)، البروفيسور ألكسندر أبي زيد، البروفيسور أنطونيو كولومبو والبروفيسور شيجيرو سايتو (الباحثون الرئيسيون في الدراسة)، واللجنة التوجيهية بأكملها.  تساهم في هذا الإنجاز المواقع التي أبدت تشجيعًا في المشاركة مع أفضل المسجلين حتى الآن – معهد دانتي بازانيز، ساو باولو، البرازيل (الدكتور شامي)، مستشفى مؤسسة القلب الوطنية ومعهد الأبحاث، دكا، بنغلاديش (الأستاذ مالك)، مستشفى هزينتيرن سيغيبيرغر، باد سيغبيرغ، ألمانيا (الدكتور ألالي) وغيرهم الكثير.  إن جميع المواقع ومحقق الموقع والفنيين ملتزمون بإنجاز ذلك.  ويعود الفضل أيضًا إلى مركز أبحاث القلب والأوعية الدموية الأوروبي ومستشفى ماونت سايناي وكلية طب إيشان لمساهمتها القيمة وتنسيقها المستمر كل يوم وهو أمر في غاية الأهمية.

في هذه المرحلة تسير التجربة بمشاركة ممتازة من محققيها ومنسقيها.  تعرب البروفيسور مهران عن حماسها بالقول، “لقد شجعني التقدم الذي نحرزه في هذه التجربة التي هي أكبر تجربة في التدخل الشرياني باستخدام القسطرة وأنا متحمسة بشكل كبير بشأن مستقبل ما يمكننا تقديمه لهؤلاء المرضى المعقدي الحالة مع التقدم في الابتكار في التدخل الشرياني باستخدام القسطرة.”

أعربت البروفيسور ماري كلود موريس، الرئيس التنفيذي لمركز أبحاث القلب والأوعية الدموية الأوروبي عن أفكارها بالقول، “يسر فريق المركز الأوروبي العمل جنبًا إلى جنب مع  مستشفى ماونت سايناي وفريق كونسيبت ميديكال.  نحن فخورون للغاية بتحقيق هذا الإنجاز الهام.  هذه الدراسة مهمة بالنسبة لمرضى السكري الذين يعانون من مرض الشريان التاجي والذين لا يزالون يتلقون العلاج على النحو الأمثل بالأجهزة الحالية.  ولا ينبغي تجاهل المرضى غير المصابين بـ كوفيد خلال فترة الجائحة.  وبفضل الباحثين ومنسقي الدراسة ذوي الدوافع العالية، تمكنا من الحصول على موافقة من جهات الأخلاقيات المعنية التي مكنتنا من تسجيل 1000 مريض بهذه الوتيرة السريعة “.

بالنسبة لشركة ذات رؤيا تقدم الابتكار، يعتبر تسجيل 1000 مريض علامة فارقة نحو اختراق محتمل في صناعة الأجهزة الطبية. كونسيبت ميديكال تتطلع كونسيبت ميديكال إلى التقدم بسرعة وإضافة معلم آخر إلى رصيدها.

نبذة عن شركة كونسيبت ميديكال إنك

يقع المقر الرئيسي لشركة كونسيبت ميديكال في تامبا بولاية فلوريدا ولديها مكاتب تشغيلية في هولندا وسنغافورة والبرازيل ووحدات تصنيع في الهند.  تتخصص الشركة في تطوير أنظمة توصيل الأدوية ولديها منصات تقنية فريدة وحاصلة على براءة اختراع يمكن نشرها لتوصيل أي دواء / عامل صيدلاني عبر الأسطح اللمعية للأوعية الدموية.

صورة:https://mma.prnewswire.com/media/1611910/Concept_Medical_NY_Times_Sqaure.jpg
ݾعار: https://mma.prnewswire.com/media/1244676/Concept_Medical_Logo.jpg

Posted on

MIAX Reports Record SPIKES Futures Trading on MGEX in August 2021, Daily Record Volume of 13,342 Contracts Traded on September 8, 2021

August 2021 Average Daily Volume of 3,904 contracts, up 144.7% over July 2021

PRINCETON, N.J. and MINNEAPOLIS, Sept. 9, 2021 /PRNewswire/ — MIAX®, creator and operator of high-performance securities exchanges, products and services, today announced average daily volume (ADV) for SPIKES® Futures in August 2021 reached 3,904 contracts, a new monthly record and representing a 144.7% increase over the 1,596 ADV in July 2021.  In addition, SPIKES Futures volume on September 8, 2021 totaled a new daily record of 13,342 contracts.

SPIKES Futures markets continue to see improved market quality, with an expanded group of market participants contributing to tight bid/ask spreads and available size to trade.  MGEX is also planning to extend its zero fee exchange policy for SPIKES Futures until December 31, 2021.

SPIKES Futures are based on the SPIKES Volatility Index, which was designed by T3 Index and measures the expected 30-day volatility in the SPDR® S&P 500® ETF (SPY), the most actively traded ETF in the world. The futures contracts are listed on MGEX and accessed via the CME Globex® platform.

“The record SPIKES Futures volumes are a testament to a new volatility trading ecosystem we are focused on building in close collaboration with our partners,” said Thomas P. Gallagher, Chairman of MGEX and Chairman & CEO of MIAX.  “We continue to devote significant resources to building out our volatility complex, with rising demand from new sectors of the end-user community expected to support our trading volumes.”

The SPIKES Volatility Index is calculated and disseminated every 100 milliseconds, offering best-in-class accuracy and stability as a result of its proprietary price-dragging technology. Futures on the SPIKES Index allow traders to benefit from the Index’s innovative design features, including its truncation methodologies and underlying SPY option component liquidity.

“Our experienced futures team is focusing on building demand from new market segments, including both institutional investors and retail trading accounts,” said Joseph W. Ferraro III, Senior Vice President, Deputy General Counsel and President of MIAX Futures.  “We are providing the trading community with a new way to trade volatility, offering a low cost product that is quickly being embraced by established volatility market participants and futures trading firms.”

SPIKES Futures contract specifications, trading rules, pricing and interface specifications are available on the MGEX website at www.mgex.com. Additional information regarding SPIKES Futures can be found at www.MIAXoptions.com/spikes/futures.

Corporate Communications Contact:

MIAX
Andy Nybo, SVP, Chief Communications Officer
609-955-2091
anybo@miami-holdings.com

About MIAX

MIAX’s parent holding company, Miami International Holdings, Inc., owns Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), the Minneapolis Grain Exchange, LLC (MGEX), and the Bermuda Stock Exchange (BSX).

MIAX, MIAX Pearl and MIAX Emerald are national securities exchanges registered with the Securities and Exchange Commission (SEC) that leverage MIAX’s industry-leading technology and infrastructure to provide U.S. listed options trading to their member firms. MIAX serves as the exclusive exchange venue for cash-settled options on the SPIKES® Volatility Index (Ticker: SPIKE), a measure of the expected 30-day volatility in the SPDR® S&P 500® ETF (SPY). In addition to options, MIAX Pearl facilitates the trading of cash equities through MIAX Pearl Equities™.

MGEX is a registered exchange with the Commodity Futures Trading Commission (CFTC) and is a Notice Registered Securities Futures Product Exchange with the SEC. MGEX serves as the exclusive market for a variety of products, including Hard Red Spring Wheat and SPIKES Futures. In addition, MGEX is a Designated Contract Market (DCM) and Derivatives Clearing Organization (DCO) under the CFTC, providing DCM, DCO and cash market services in an array of asset classes.

The BSX is a leading electronic international securities market regulated by the Bermuda Monetary Authority (BMA) specializing in the listing and trading of capital market instruments such as equities, debt issues, funds, hedge funds, derivative warrants and insurance linked securities. A full member of the World Federation of Exchanges and affiliate member of the International Organization of Securities Commissions, the BSX is globally recognized, including by the SEC.

MIAX’s executive offices and National Operations Center are located in Princeton, NJ, with additional offices located in Miami, FL, Minneapolis, MN, and Hamilton, Bermuda.

To learn more about MIAX visit www.MIAXOptions.com.

To learn more about MGEX visit www.mgex.com.

To learn more about the BSX visit www.BSX.com.

Disclaimer and Cautionary Note Regarding Forward-Looking Statements
The press release shall not constitute an offer to sell or a solicitation of an offer to purchase any securities of Miami International Holdings, Inc. (together with its subsidiaries, the Company), and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer; solicitation or sale would be unlawful. This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

All third-party trademarks (including logos and icons) referenced by the Company remain the property of their respective owners. Unless specifically identified as such, the Company’s use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between the owners of these trademarks and the Company. Any references by the Company to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Logo – https://mma.prnewswire.com/media/1396492/MIAX_Logo.jpg

Posted on

Winner Medical Celebrates 30th Anniversary with Continued Focus on Sustainable Development

SHENZHEN, China, Sept. 10, 2021 /PRNewswire/ — Winner Medical Co., Ltd. (300888.SZ), a leading manufacturer of high-quality medical and consumer products, celebrates its 30th anniversary this year alongside the release of its first annual corporate social responsibility report which highlights its continued commitment to sustainable, innovative, environmentally friendly development.

Winner Medical Celebrates 30th Anniversary with Continued Focus on Sustainable Development

The CEO of Winner Medical, Jianquan Li said, “Winner Medical’s ‘green conscience’ has been ingrained in our DNA from the outset 30 years ago, proven by our deep commitment to building sustainable, green and environmentally friendly enterprises. Through our technological and scientific expertise, we have been constantly reducing our energy consumption and carbon emissions throughout the entire production chain. We will continue to have the sustainable and ecologically-focused mindset we’ve always had.”

The commitment starts from the raw materials for production. Products of Purcotton, the subsidiary of Winner Medical, are all made of cotton. Cotton, one of the most sustainable natural fibers, only needs six months from planting to harvesting. Cotton products are naturally biodegradable within 3 months and become organic fertilizer without undue burden to the environment. Additionally, cotton is one of the most drought-tolerant crops and planting consumes only 2.3% of water needed for agricultural production and 3% of related cultivated areas, providing 36% of the world’s fiber while fighting against soil erosion and combatting desertification.

Fully aware of its environmental responsibilities, Winner Medical consistently minimizes negative environmental impacts during the manufacturing process of its products by replacing coal with natural gas, recycling water and other measures. Through continuous optimization of production processes and technologies, the consumption of energy and resources has been reduced to create an environmentally friendly company. Winner Medical is devoted to providing customers with a commitment to expertise and peace of mind as a trustworthy industry leader that adheres to its core principle of “quality is superior to profit.”

In April this year, Winner Medical unveiled its first annual corporate social responsibility report which comprehensively outlined the company’s practices and achievements in Environmental, Social, and Corporate Governance (ESG). Since the beginning of 2021, surveys have been held to calculate the value of energy use, energy conservation and environmental protection measures of the entire company including its subsidiaries. The compiled data is being used to formulate a realistic and measurable timeframe for the company’s peak carbon and carbon neutrality goals. The company has put into motion and integrated the concept of emissions reduction throughout its entire supply chain.

About Winner Medical

Winner Medical Co., Ltd. (stock code: 300888), founded in 1991 and headquartered in Shenzhen, China, is a large-scale health company that realizes the coordinated development of the medical and consumer sectors through its three major brands: “Winner“, “Purcotton” and “PureH2B“. The company is committed to rendering more high-quality life choices for users and consumers and to creating value for a better life.

With 30 years of experience in the production of medical supplies, Winner is a leading medical consumables brand in the Chinese market as well as a brand with a global vision. Purcotton, as a brand of daily necessities, has inherited the company’s 30-year experience of manufacturing medical supplies. Using pure cotton as raw material, the brand aims to create a series of high-end cotton daily necessities that are healthy, comfortable and environmentally friendly. PureH2B is created as a life platform to offer consumers select things that are high-quality, healthy, and beautiful from around the world.

For more information, please visit: https://www.winnermedical.com/

Photo – https://mma.prnewswire.com/media/1612532/1.jpg